These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

269 related items for PubMed ID: 23811439

  • 1. Formulation development and evaluation of Diltiazem HCl sustained release matrix tablets using HPMC K4M and K100M.
    Qazi F, Shoaib MH, Yousuf RI, Qazi TM, Mehmood ZA, Hasan SM.
    Pak J Pharm Sci; 2013 Jul; 26(4):653-63. PubMed ID: 23811439
    [Abstract] [Full Text] [Related]

  • 2. Drug release kinetic analysis and prediction of release data via polymer molecular weight in sustained release diltiazem matrices.
    Adibkia K, Ghanbarzadeh S, Mohammadi G, Khiavi HZ, Sabzevari A, Barzegar-Jalali M.
    Drug Res (Stuttg); 2014 Mar; 64(3):118-23. PubMed ID: 23986307
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The effect of pH and ionic strength of dissolution media on in-vitro release of two model drugs of different solubilities from HPMC matrices.
    Asare-Addo K, Conway BR, Larhrib H, Levina M, Rajabi-Siahboomi AR, Tetteh J, Boateng J, Nokhodchi A.
    Colloids Surf B Biointerfaces; 2013 Nov 01; 111():384-91. PubMed ID: 23850747
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Spray-dried O-carboxymethyl chitosan as potential hydrophilic matrix tablet for sustained release of drug.
    Bresolin JR, Largura MC, Dalri CC, Hoffer G, Rodrigues CA, Lucinda-Silva RM.
    Drug Dev Ind Pharm; 2014 Apr 01; 40(4):503-10. PubMed ID: 23594298
    [Abstract] [Full Text] [Related]

  • 10. Two different approaches for the prediction of in vivo plasma concentration-time profile from in vitro release data of once daily formulations of diltiazem hydrochloride.
    Bendas ER.
    Arch Pharm Res; 2009 Sep 01; 32(9):1317-29. PubMed ID: 19784589
    [Abstract] [Full Text] [Related]

  • 11. Studies in release behavior of diltiazem HCl from matrix tablets containing (hydroxypropyl)methyl cellulose and xanthan gum.
    Gohel MC, Amin AF, Patel KV, Panchal MK.
    Boll Chim Farm; 2002 Sep 01; 141(1):21-8. PubMed ID: 12064053
    [Abstract] [Full Text] [Related]

  • 12. Evaluation of drug release kinetics from ibuprofen matrix tablets using HPMC.
    Shoaib MH, Tazeen J, Merchant HA, Yousuf RI.
    Pak J Pharm Sci; 2006 Apr 01; 19(2):119-24. PubMed ID: 16751122
    [Abstract] [Full Text] [Related]

  • 13. Preliminary investigations in matrix-based tablet formulations of diltiazem hydrochloride containing succinic acid-treated methylcellulose.
    Gohel MC, Patel MM, Chhabaria MT, Buaria CP.
    Pharm Dev Technol; 1998 Nov 01; 3(4):453-9. PubMed ID: 9834947
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Development of a HPMC-based controlled release formulation with hot melt extrusion (HME).
    Ma D, Djemai A, Gendron CM, Xi H, Smith M, Kogan J, Li L.
    Drug Dev Ind Pharm; 2013 Jul 01; 39(7):1070-83. PubMed ID: 22803806
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Diltiazem Hydrochloride Floating Matrix Tablet: Formulation and in vitro-in vivo Evaluation.
    Koradia KD, Jotaniya BK, Koradia HD.
    Cardiovasc Hematol Disord Drug Targets; 2024 Jul 01; 24(2):110-124. PubMed ID: 39034726
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.